fda glp-1 warning news september 2025 Beyond the Headlines: Letters to Compounders FDA issued 25 warning letters

Stay hydrated and manage side effects: Some people experience nausea, constipation, or bloating with GLP-1 medications

Under current US compounding rules, pharmacies and outsourcing facilities may only compound medicines using active pharmaceutical ingredients (bulk drug substances) that form part of an FDA-approved medicine, appear in an official United States Pharmacopeia or National Formulary monograph, or are included on the FDAs bulk drug substance list

Pennsylvania ranked second overall in total Medicaid spend, with nearly $298 million in total spending and $106 per enrollee

Clinical data show that 4060% of users maintain most of their weight loss long-term when they combine supervised tapering, consistent exercise, high protein intake, and behavioral strategies